Keflex and Ear discomfort - a phase IV clinical study of FDA data

Summary:

Ear discomfort is reported as a side effect among people who take Keflex (cephalexin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Zometa, and have Metastases to bone.

The phase IV clinical study analyzes which people have Ear discomfort when taking Keflex. It is created by eHealthMe based on reports of 14,902 people who have side effects when taking Keflex from the FDA, and is updated regularly.

What is Keflex?

Keflex has active ingredients of cephalexin. It is often used in infection. eHealthMe is studying from 15,844 Keflex users. Check the latest studies of Keflex.

What is Ear discomfort?

Ear discomfort is found to be associated with 831 drugs and 1,349 conditions by eHealthMe. Check the latest studies of Ear discomfort.

On Jul, 12, 2026

14,902 people reported to have side effects when taking Keflex.
Among them, 30 people (0.2%) have Ear discomfort.

Among these 30 people:

How long have people been on Keflex when they have Ear discomfort? *

What is the gender of people who have Ear discomfort when taking Keflex? *

female: 72.41 %
male: 27.59 %

What is the age of people who have Ear discomfort when taking Keflex? *

What are other drugs people take besides Keflex? *

What are other side effects people have besides Ear discomfort? *

Chest Pain: 16 people, 53.33%
Fatigue (feeling of tiredness): 15 people, 50.00%
Joint Pain: 14 people, 46.67%
Weight Decreased: 14 people, 46.67%
Fall: 13 people, 43.33%
Headache (pain in head): 12 people, 40.00%
Cough: 12 people, 40.00%
Pain In Extremity: 12 people, 40.00%
Rhinorrhea (watery mucus discharge from the nose): 12 people, 40.00%
Weakness: 12 people, 40.00%

What are the existing conditions these people have? *

Arthritis (form of joint disorder that involves inflammation of one or more joints): 6 people, 20.00%
Metastases To Bone (cancer spreads to bone): 6 people, 20.00%
Psoriasis (immune-mediated disease that affects the skin): 3 people, 10.00%
Multiple Myeloma (cancer of the plasma cells): 2 people, 6.67%
Osteoporosis (bones weak and more likely to break): 2 people, 6.67%
Blood Calcium Abnormal: 2 people, 6.67%
Cerebrovascular Disorder (disease of brain): 2 people, 6.67%
Femur Fracture: 2 people, 6.67%
Multiple Allergies (allergy to multiple agents): 2 people, 6.67%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Keflex and have Ear discomfort?

- Check whether Ear discomfort is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Keflex:

Keflex (15,844 reports)

Ear discomfort treatments and more:

Ear discomfort (11,548 reports)

Browse all side effects of Keflex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ear discomfort:

Ear discomfort (831 drugs)

Browse all the conditions that are associated with Ear discomfort:

Ear discomfort (1,349 conditions)

Related publications that referenced our studies

Agrawal A, Rao M, Jasdanwala S, Mathur A, Eng M, "Cephalexin Induced Cholestatic Jaundice", Case reports in gastrointestinal medicine, 2014 Aug .
Agrawal A, Rao M, Jasdanwala S, Mathur A, Eng M, "Cephalexin Induced Cholestatic Jaundice", Case reports in gastrointestinal medicine, 2014 Aug .

How the study uses the data?

The study uses data from the FDA. It is based on cephalexin (the active ingredients of Keflex) and Keflex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.